Results 111 to 120 of about 48,831 (199)

Adverse pregnancy outcomes in women with type 1 diabetes: A nationwide, population‐based study, 1999–2021

Acta Obstetricia et Gynecologica Scandinavica, EarlyView.
Women with type 1 diabetes had higher odds for most adverse pregnancy outcomes. In 2015–2021 compared to 1999–2014, women with type 1 diabetes had a notable reduction in congenital malformations, while immigrant women with type 1 diabetes had increased odds of delivering large for gestational age infants.
Astrid Melteig Stalheim, Roy Miodini Nilsen, Siri Vangen, Eline Skirnisdottir Vik, Patji Alnæs‐Katjavivi, Marjolein Memelink Iversen, Tore Julsrud Berg, Ragnhild Bjarkøy Strandberg   +7 more
wiley   +1 more source

First-trimester prediction and prevention of preterm pre-eclampsia in women with chronic hypertension. [PDF]

Ultrasound Obstet Gynecol
Rolnik DL, Gil-Pugliese S, Syngelaki A, Bujold E, Wright D, Poon LC, Nicolaides KH, ASPRE and SPREE Collaborators.   +7 more
europepmc   +1 more source

The effect of antihypertensive treatment on longitudinal changes in PLGF and sFlt‐1 in women with new onset hypertension in pregnancy

Acta Obstetricia et Gynecologica Scandinavica, EarlyView.
In pregnant women with new‐onset hypertension starting antihypertensives, some achieve tight BP control within a week (Group 1‐blue line), while others respond slower (Group 2‐red line). Group 1 showed higher Log10PLGF levels, but Log10sFlt‐1 did not differ between groups. Over time, Log10PLGF declined in both groups, while Log10sFlt‐1 remained stable.
Edward Tyrell, Katherine G. Y. Lau, Martyna Bednorz, Kypros H. Nicolaides, Nikos A. Kametas   +4 more
wiley   +1 more source

Longitudinal maternal hemodynamics in high-risk pregnancies with different subtypes of pre-eclampsia. [PDF]

Ultrasound Obstet Gynecol
Lin J, Wang X, Chen Y, Nguyen-Hoang L, Tai AST, Wong IS, Chen XY, Ng MH, Leung HHY, Lee APW, Poon LC.   +10 more
europepmc   +1 more source

Testing the Broad Definition of Pre‐Eclampsia: Should Chronic Hypertension With Fetal Growth Restriction Be Included?

BJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.
Peter von Dadelszen, Terry Lee, Joel Singer, Laura A. Magee, For the CHIPS Study Group   +4 more
wiley   +1 more source

Improved risk stratification for placenta‐mediated complications through the use of mid‐gestational uterine artery Doppler: A retrospective cohort study

Acta Obstetricia et Gynecologica Scandinavica, EarlyView.
Mid‐gestational uterine artery Doppler refines first‐trimester screening risk stratification for placenta‐mediated complications. Sequential assessment reclassifies women into four combined groups, identifying a distinct highest‐risk subgroup (H1H2) with over 40% adverse outcomes.
Christina Ammari, Raffaele Napolitano, Daniel Stott, Davide Casagrandi, Diane Nzelu, Sara L. Hillman   +5 more
wiley   +1 more source

The recent advancements of single-cell RNA sequencing in pre-eclampsia. [PDF]

Front Med (Lausanne)
Tang S, Lin X.
europepmc   +1 more source

Pre‐eclampsia risk‐stratified planned birth at term: A survey of women’s perspectives on acceptability and risk communication

Acta Obstetricia et Gynecologica Scandinavica, EarlyView.
The survey was designed to assess participants' acceptability of the PREVENT‐PE trial, with survey questions adapted to address each acceptability construct: affective attitude (comfort with involvement); burden (effort taken for involvement); ethicality (screening is fair for all); perceived effectiveness (perceptions of likely benefit); intervention ...
James Goadsby, Angel Leung, Sergio A. Silverio, Laura A. Magee, Peter von Dadelszen, Argyro Syngelaki, Kypros H. Nicolaides, Kayleigh S. Sheen   +7 more
wiley   +1 more source

Subclinical atherosclerosis in women after pre-eclampsia: a systematic review and meta-analysis. [PDF]

Heart
Yao JV, Wang B, Ganes A, Peters S, Taylor A, Brennecke S, Winship I, Zentner D.   +7 more
europepmc   +1 more source

Priming of labor with tafoxiparin in nulliparous term pregnant women with unripe cervix—Proof‐of‐concept and dose‐finding results from a randomized controlled trial

Acta Obstetricia et Gynecologica Scandinavica, EarlyView.
This study shows that tafoxiparin 300 mg can increase the rate of cervical ripening and the likelihood of spontaneous onset of labor, while also reducing the duration of labor in women achieving spontaneous onset of labor. The favorable safety profile of tafoxiparin suggests suitability for routine clinical use, including home administration.
Gunvor Ekman‐Ordeberg, Maria Jonsson, Marie Blomberg, Malin Melin, Ylva Stjernholm‐Vladic, Sebastian B. Gidlöf, Dag Wide‐Swensson, Kati Tihtonen, Inge C. Olsen, Lena Degling‐Wikingsson, Per Blom, Leena Rahkonen   +11 more
wiley   +1 more source